论文部分内容阅读
目的:比较盐酸左氧氟沙星与氧氟沙星用于治疗盆腔炎患者的临床疗效。方法:选取2011年7月—2013年3月间收治的盆腔炎患者72例,将其分为盐酸左氧氟沙星组与氧氟沙星组,各组36例;盐酸左氧氟沙星组患者给予盐酸左氧氟沙星治疗,氧氟沙星组给予氧氟沙星治疗,比较两组患者治疗后的总有效率和不良反应的发生率。结果:盐酸左氧氟沙星组患者治疗后的总有效率为94.44%显著高于氧氟沙星组为75.00%(P<0.05);盐酸左氧氟沙星组患者用药后不良反应的发生率为5.56%显著低于氧氟沙星组为25.00%(P<0.05)。结论:盐酸左氧氟沙星用于治疗盆腔炎患者的效果较为显著,不良反应的发生率较低。
Objective: To compare the clinical efficacy of levofloxacin hydrochloride and ofloxacin in the treatment of patients with pelvic inflammatory disease. Methods: Seventy-two patients with pelvic inflammatory disease were selected from July 2011 to March 2013, and were divided into three groups: levofloxacin hydrochloride group and ofloxacin group, with 36 patients in each group. Patients in levofloxacin group were treated with levofloxacin hydrochloride, Ofloxacin group was treated with ofloxacin, the total effective rate and the incidence of adverse reactions were compared between the two groups after treatment. Results: The total effective rate of levofloxacin hydrochloride group after treatment was 94.44%, which was significantly higher than that of ofloxacin group (75.00%, P <0.05). The incidence of adverse reactions in levofloxacin hydrochloride group was 5.56% Ofloxacin group was 25.00% (P <0.05). Conclusion: Levofloxacin Hydrochloride for the treatment of patients with pelvic inflammatory disease is more significant, the incidence of adverse reactions is low.